Universe Pharmaceuticals Inc
UPC3.395USD
-0.085-2.44%
Market hours （ET）Quotes delayed by 15 min
1.91MMarket Cap
--P/E TTM
More Details of Universe Pharmaceuticals Inc Company
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Company Info
Ticker SymbolUPC
Company nameUniverse Pharmaceuticals Inc
IPO dateMar 23, 2021
CEOMr. Gang Lai
Number of employees225
Security typeOrdinary Share
Fiscal year-endMar 23
Address265 Jingjiu Avenue
CityJI'AN
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code343100
Phone867968403309
Websitehttp://www.universe-pharmacy.com/
Ticker SymbolUPC
IPO dateMar 23, 2021
CEOMr. Gang Lai
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
23.02M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Sales of TCMD products
14.03M
60.92%
Sales of third-party products
9.00M
39.08%
Shareholding Stats
Updated: Thu, May 15
Updated: Thu, May 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Sununion Holding Group Ltd
0.62%
UBS Financial Services, Inc.
0.05%
Other
99.34%
Shareholders
Shareholders
Proportion
Sununion Holding Group Ltd
0.62%
UBS Financial Services, Inc.
0.05%
Other
99.34%
Shareholder Types
Shareholders
Proportion
Corporation
0.62%
Investment Advisor
0.05%
Other
99.34%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
15
3.73K
0.66%
-14.56K
2025Q1
15
3.73K
8.84%
-14.56K
2024Q4
15
702.49K
4.61%
+518.42K
2024Q3
12
183.86K
3.78%
+44.54K
2024Q2
8
139.13K
0.94%
-3.04K
2024Q1
8
138.86K
57.13%
-3.66K
2023Q4
9
139.20K
57.27%
-3.80K
2023Q3
13
139.26K
57.29%
-143.15K
2023Q2
13
139.86K
57.87%
-142.30K
2023Q1
15
139.56K
57.75%
-143.20K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Sununion Holding Group Ltd
3.47K
0.62%
--
--
Apr 29, 2025
UBS Financial Services, Inc.
266.00
0.05%
+266.00
--
Mar 31, 2025
Sabby Management, LLC
--
0%
-8.33K
-100.00%
Mar 31, 2025
Anson Funds Management LP.
--
0%
-5.76K
-100.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
--
0%
-2.00
-100.00%
Mar 31, 2025
MML Investors Services, LLC
--
0%
-390.00
-100.00%
Dec 31, 2024
Quadrature Capital LLP
--
0%
-41.00
-100.00%
Dec 31, 2024
Virtu Americas LLC
--
0%
-28.00
-100.00%
Dec 31, 2024
Geode Capital Management, L.L.C.
--
0%
-2.00
-100.00%
Oct 31, 2024
Two Sigma Investments, LP
--
0%
-151.00
-100.00%
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Date
Type
Ratio
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Mar 20, 2025
Merger
40<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Nov 14, 2024
Merger
15<1
Jul 27, 2023
Merger
6<1
Jul 27, 2023
Merger
6<1
View more
